Skip to main content
logo
Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.4087
-0.0003 (-0.07%)
At close: Aug 21, 2026, 4:00 PM EDT
0.4099
+0.0012 (0.29%)
After-hours: Aug 21, 2026, 4:00 PM EDT

Cellyan Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Net Income
-1.14-0.031.331
Depreciation & Amortization
0.691.070.930.71
Loss (Gain) From Sale of Assets
0.03--0-
Loss (Gain) From Sale of Investments
-0.080.04--
Provision & Write-off of Bad Debts
0.04---
Change in Accounts Receivable
0.84-0.92-2.05-0.93
Change in Inventory
0.20.38-0.74-0.19
Change in Accounts Payable
-0.940.4-0.110.96
Change in Unearned Revenue
0-0.07-0.080.21
Change in Income Taxes
-0.09-0.110.20.02
Change in Other Net Operating Assets
-0.31-0.190.13-0.05
Operating Cash Flow
-0.750.57-0.391.73
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Capital Expenditures
-0.04-0.07-0.05-0.11
Sale of Property, Plant & Equipment
--0.03-
Sale (Purchase) of Intangibles
-0.01-0.09-0.04-0
Investment in Securities
0.9-2.3--
Other Investing Activities
--0.01-0.01
Investing Cash Flow
0.86-2.45-0.04-0.13

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Long-Term Debt Issued
2.11.592.140.19
Long-Term Debt Repaid
-2.73-2.52-1.77-1.34
Net Debt Issued (Repaid)
-0.63-0.930.37-1.16
Issuance of Common Stock
-4.30.51-
Other Financing Activities
--1.38-0.35-
Financing Cash Flow
-0.6320.54-1.16

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Foreign Exchange Rate Adjustments
-00.0100
Net Cash Flow
-0.530.120.10.44

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Free Cash Flow
-0.790.5-0.451.61
Free Cash Flow Growth
----
Free Cash Flow Margin
-5.86%2.46%-2.68%12.84%
Free Cash Flow Per Share
-0.030.05-0.060.24
Levered Free Cash Flow
-6.512.16-2.93-
Unlevered Free Cash Flow
-6.422.22-2.88-

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Cash Interest Paid
0.090.10.080.06
Cash Income Tax Paid
0.040.29--
Change in Working Capital
-0.3-0.52-2.650.01
SEC Filings: 10-K · 10-Q